77 related articles for article (PubMed ID: 3447759)
21. High-density lipoprotein cholesterol and triglycerides as therapeutic targets for preventing and treating coronary artery disease.
Gotto AM
Am Heart J; 2002 Dec; 144(6 Suppl):S33-42. PubMed ID: 12486414
[TBL] [Abstract][Full Text] [Related]
22. [Coronary arteriosclerosis and high-density lipoprotein cholesterol].
Kurdanov KhA; Polesskiĭ VA; Perova NV
Klin Med (Mosk); 1986 Feb; 64(2):80-3. PubMed ID: 3702301
[No Abstract] [Full Text] [Related]
23. [Does HDL-cholesterol determination facilitate the assessment of risk in coronary patients?].
Schmid B; Hartmann G
Schweiz Med Wochenschr; 1983 Dec; 113(50):1923-5. PubMed ID: 6665537
[TBL] [Abstract][Full Text] [Related]
24. Inflammatory/antiinflammatory properties of high-density lipoprotein distinguish patients from control subjects better than high-density lipoprotein cholesterol levels and are favorably affected by simvastatin treatment.
Ansell BJ; Navab M; Hama S; Kamranpour N; Fonarow G; Hough G; Rahmani S; Mottahedeh R; Dave R; Reddy ST; Fogelman AM
Circulation; 2003 Dec; 108(22):2751-6. PubMed ID: 14638544
[TBL] [Abstract][Full Text] [Related]
25. Lipid peroxides in blood from patients with atherosclerosis of coronary and peripheral arteries.
Plachta H; Bartnikowska E; Obara A
Clin Chim Acta; 1992 Oct; 211(1-2):101-12. PubMed ID: 1468149
[TBL] [Abstract][Full Text] [Related]
26. [Serum lipids of alcoholics before and following abstinence. Significance for coronary risk].
Clemens MR; Schied HW; Waller HD
J Clin Chem Clin Biochem; 1986 Jun; 24(6):369-74. PubMed ID: 3746201
[TBL] [Abstract][Full Text] [Related]
27. A long-term follow-up study of serum lipid levels and coronary heart disease in the elderly.
Li JZ; Chen ML; Wang S; Dong J; Zeng P; Hou LW
Chin Med J (Engl); 2004 Feb; 117(2):163-7. PubMed ID: 14975195
[TBL] [Abstract][Full Text] [Related]
28. Changes in lipid measures and incident coronary heart disease: Tehran Lipid & Glucose Study.
Nejat A; Mirbolouk M; Mohebi R; Hasheminia M; Tohidi M; Saadat N; Azizi F; Hadaegh F
Clin Biochem; 2014 Sep; 47(13-14):1239-44. PubMed ID: 24657509
[TBL] [Abstract][Full Text] [Related]
29. Comparison of cardiovascular risk and lipid profiles in patients undergoing aortic valve surgery versus those undergoing coronary artery bypass grafting.
Novaro GM; Pearce GL; Sprecher DL; Griffin BP
J Heart Valve Dis; 2001 Jan; 10(1):19-24. PubMed ID: 11206763
[TBL] [Abstract][Full Text] [Related]
30. Achieving optimal lipid goals in patients with coronary artery disease.
Karalis DG; Subramanya RD; Hessen SE; Liu L; Victor MF
Am J Cardiol; 2011 Mar; 107(6):886-90. PubMed ID: 21247526
[TBL] [Abstract][Full Text] [Related]
31. Effects of a fish oil supplement on blood pressure and serum lipids in patients treated for coronary artery disease.
Bairati I; Roy L; Meyer F
Can J Cardiol; 1992; 8(1):41-6. PubMed ID: 1617510
[TBL] [Abstract][Full Text] [Related]
32. Lipid profile components and incident cerebrovascular events versus coronary heart disease; the result of 9 years follow-up in Tehran Lipid and Glucose Study.
Tohidi M; Mohebi R; Cheraghi L; Hajsheikholeslami F; Aref S; Nouri S; Azizi F; Hadaegh F
Clin Biochem; 2013 Jun; 46(9):716-21. PubMed ID: 23531403
[TBL] [Abstract][Full Text] [Related]
33. A comparison of the levels of total serum cholesterol (1974-1984) and its relations to ischaemic heart disease in Singapore and the United States of America.
Chew WL; Mah PK; Tan YT; Cheong CK
Singapore Med J; 1988 Feb; 29(1):6-10. PubMed ID: 3406770
[No Abstract] [Full Text] [Related]
34. [Serum lipid and lipoprotein levels in populations of Beijing].
Li JZ
Zhonghua Yi Xue Za Zhi; 1988 Jun; 68(6):327-31, 24. PubMed ID: 3228725
[No Abstract] [Full Text] [Related]
35. [The importance of triglycerides and HDL cholesterol as coronary disease risk factors].
Nikkilä M; Niemelä K; Koivula T; Sisto T
Duodecim; 1989; 105(15):1307-12. PubMed ID: 2791916
[No Abstract] [Full Text] [Related]
36. Effect of the dried powder extract, water soluble of garlic (Allium sativum) on cholesterol, triglyceride and high density lipoprotein in the blood.
Nitiyanant W; Ploybutr S; Wasuwat S; Tandhanand S
J Med Assoc Thai; 1987 Nov; 70(11):646-8. PubMed ID: 3443797
[No Abstract] [Full Text] [Related]
37. [The effect of ethyl-chlorophenoxyisobutyrate on the serum lipids in coronary sclerosis].
Keller L; Rétsági G; Sebestyén M; Diczendy S; Erdélyi G
Z Gesamte Inn Med; 1966 Mar; 21(6):169-72. PubMed ID: 5988081
[No Abstract] [Full Text] [Related]
38. [Findings or disease--lipid metabolism with reference to the heart].
Wolfram G
Internist (Berl); 1986 Mar; 27(3):158-65. PubMed ID: 3519502
[No Abstract] [Full Text] [Related]
39. [Changes in serum lipid levels in coronary heart disease with energy stagnancy and blood stasis].
Xu QY
Zhong Xi Yi Jie He Za Zhi; 1985 May; 5(5):265-6, 258. PubMed ID: 3159492
[No Abstract] [Full Text] [Related]
40. A study on serum triglyceride and lipoproteins cholesterol in coronary heart disease patients.
Awan ZA; Baseer A
J Pak Med Assoc; 1995 Oct; 45(10):263-6. PubMed ID: 8714621
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
